Our R&D Centre in Hyderabad is built on a vast area, providing comprehensive infrastructure for groundbreaking innovation. This investment in infrastructure is key to our status as one of the top pharma companies in India.
As a global leader in developing and manufacturing a wide range of brands and generics, including oncology and ARV drugs, our commitment to innovation drives our progress. Our pharmaceutical company in Hyderabad plays a crucial role in bridging the gap between cutting-edge drug discovery and the real-world needs of patients.
Launched first generic 'COVIFOR' (Remdesivir) in India for the treatment of COVID-19 (licensing agreement with Gilead Sciences Inc.)
Basic manufacturer of Oseltamivir (sub-licensing agreement with Hoffman-La Rosche, Switzerland).
Click here for more...
In the pharmaceutical industry, innovation is at the core of what we do. At Hetero Healthcare, we develop new drugs and therapeutic biological products through structured innovation strategies, ensuring we meet the demand for pharmaceutical manufacturers in India.
We aim to improve the quality life of the people with our product line and along with a continuous Research and Development process. To be Recognized as an Innovative Pharmaceutical Company satisfying needs of the Customers, Doctors and Chemists.
Doctors
Formulation Products
Field Force
At Hetero Healthcare, our commitment to patient well-being extends beyond just providing innovative medications.
Read MoreAs a leading innovative pharmaceutical company in India, Hetero Healthcare recognizes its responsibility not just to improve human health but also to protect the planet.
Read MoreEmbarking on the path to parenthood is an exciting and significant chapter for many couples. But conception, the very foundation of this journey, can be a complex biological process.
Read MoreHetero Healthcare Gastrocare Division participated in 8th National Meeting of Colitis & Crohn’s Foundation (India), 2nd Round Table Meeting of BRICS IBD Consortium at Vizag from 4th - 6th October 2024.
Read MoreOur Gastrocare Team of Hetero Healthcare held a Managers Development Program (MDP) in Mumbai from 12th to 14th September 2024 to enhance the Skills and Knowledge of Managers needed to lead effectively and drive organisational success.
Read MoreILCC 2024 was the third National conference of STII organised by ILBS. It was held on September 28th and 29th, 2024, at The Grand New Delhi.
Read MoreDIAQUIL Launch: A New Breakthrough in Diabetic Foot Care by the DIASPA team at Hetero Healthcare
Read MoreThe Telangana team received Blazers from our beloved Director Mr. Namburi Bose and Assoc.
Read MoreCongratulations, esteemed members of our exceptional KRIS Team!
Read MoreCopyright ©2024 All Rights Reserved by Hetero Healthcare Limited.